Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.35 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Urea SCHEMBL1835314 | 0.92 | ALOX5 (0.46) | ALOX5CYP2D6EPHX1CYP1A2PARP15 | |
| Urea SCHEMBL11805177 | 0.90 | ALOX5 (0.48) | ALOX5CYP2D6EPHX1CYP1A2 | |
| Urea SCHEMBL1837609 | 0.90 | ALOX5 (0.48) | ALOX5CYP2D6EPHX1CYP1A2 | |
| Bicarbonate SCHEMBL10453278 | 0.90 | CYP1A2 (0.39) | ALOX5CYP2D6EPHX1SLC1A3SLC1A2 | |
| Acetic Acid SCHEMBL27585871 | 0.87 | CYP1A2 (0.37) | ALOX5CYP2D6EPHX1SLC1A3SLC1A2 | |
| Bicarbonate SCHEMBL6470832 | 0.87 | CYP1A2 (0.42) | ALOX5CYP2D6EPHX1CYP1A2LMNA | |
| Cyclohexane SCHEMBL28777359 | 0.85 | CYP1A2 (0.41) | ALOX5CYP2D6EPHX1SLC1A3SLC1A2 | |
| Propionic Acid SCHEMBL19813178 | 0.85 | FFAR3 (0.50) | ALOX5CYP2D6EPHX1CYP1A2LMNA | |
| Acetic Acid SCHEMBL2485175 | 0.85 | CYP1A2 (0.41) | ALOX5CYP2D6EPHX1SLC1A3SLC1A2 | |
| Bicarbonate SCHEMBL2862271 | 0.84 | ALOX5 (0.38) | ALOX5CYP2D6EPHX1SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133293-A1 | USE OF N-SUBSTITUTED AZABICYCLOALKANE DERIVATIVES FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000030639-A1 | USE OF N-SUBSTITUTED AZABICYCLOALKANE DERIVATIVES FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-02 | — | — | WO | disclosed |